藥明生物
WuXi Biologics (Cayman) IncUSUSDWuXi Biologics (Cayman) Inc (US:WXIBF) — Biotechnology. Börside arv, kus ettevõtte aktsiatega kaubeldakse: 2. Sellel lehel — hind ja graafik, dividendid, suurimad aktsionärid ja aktsiate arvu ajalugu.
Ettevõtte kohta
- Veebileht
- wuxibiologics.com
- Sektor
- Healthcare · Biotechnology
- Peakontor
- Wuxi, China
- Tegevjuht
- Dr. Zhisheng Chen Ph.D.
- Töötajad
- 14 705
- Ringluses olevad aktsiad
- Vabalt kaubeldavad aktsiad
- 3.71 mld
- Turukapitalisatsioon
- 221.69 mld HKD
- Siseringi isikud
- 10.12%
- Institutsionaalsed investorid
- 36.36%
- Õiguslik vorm
- OSBR
- ISIN
- KYG970081173
- LEI
- 5493001TD2TH6VDTJU11
Kirjeldus
WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People's Republic of China, North America, Europe, Singapore, Japan, South Korea, Australia, and Brazil. It operates through two segments: Biologics and XDC. The company provides a suite of solutions for biologic discovery, from concept to IND, that seamlessly transits to CMC and downstream process development through its contract research, development, and manufacturing organization platforms, including WuXiBody, SDArBodY, T cell engager, Tumor Associated Antigens (TAA) mAb Technology, Single B Cell Cloning Technology, WuXia, WuXiUP, WuXiUI, and WuXiHigh. It engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, production and sales of medicals, and biologics clinical and manufacturing services; research and development in relation to biologics; international sales contracting service; vaccine contract development and manufacturing organization (CDMO) and related business; development, production, and distribution of biotechnological products; and engages in investment and material supplier activities. WuXi Biologics (Cayman) Inc. was incorporated in 2014 and is headquartered in Wuxi, China.
Dividendid
Dividendimakseid ei leitud (kontrollitud 10.10.2026). Ettevõte ilmselt dividende ei maksa.
Selle nädala uudised
Pressiteated ettevõtte investorite veebisaidilt, uuendatakse iga päev. Lingid viivad ettevõtte veebilehele. Pealkirjad on originaalkeeles, nagu ettevõtte veebilehel.
Suurimad omanikud
| Omanik | Osalus | Aktsiad | Aruande kuupäev |
|---|---|---|---|
| VANGUARD STAR FUNDS-Vang… | 1.34% | 55.13 mln | 2026-07-31 |
| VANGUARD Intl Eqy. INDEX… | 1.27% | 52.41 mln | 2026-07-31 |
| Chen (Zhisheng) (Chief E… | ≈1.19% | 49.19 mln | 2026-09-11 |
| iShares, Inc.-iShares Co… | 0.97% | 40.12 mln | 2026-08-31 |
| VANGUARD WORLD FUND-Vang… | 0.92% | 37.93 mln | 2026-05-31 |
| American Century ETF Tru… | 0.27% | 11.01 mln | 2026-08-31 |
| J.P. Morgan Exch-Trd Fd.… | 0.26% | 10.87 mln | 2026-07-31 |
| VANGUARD Intl Eqy. INDEX… | 0.22% | 8.96 mln | 2026-07-31 |
| iShares, Inc.-iShares MS… | 0.22% | 8.91 mln | 2026-08-31 |
| Baird Funds Inc-Baird Ch… | 0.21% | 8.77 mln | 2026-07-31 |
| iShares Trust-iShares MS… | 0.21% | 8.76 mln | 2026-08-31 |
| Zhou (Weichang) (Chief T… | ≈0.14% | 5.6 mln | 2025-06-02 |
| Gu (Xuejun Sherry) (Chie… | ≈0.03% | 1.37 mln | 2026-08-24 |
| Boston Common Asset Mana… | 0.02% | 869 000 | 2024-03-31 |
| Li (Ge) (Chairman of the… | — | — | 2026-01-20 |